SOUTH KOREA · OPENDART
Rznomics Inc.
알지노믹스 · 476830 · KOSDAQ · Healthcare · Biotechnology
Score
37.0
Insider timeline
One insider bought, once (10 Jul). The share closed at 33,150.00 that day and at 22,100.00 most recently (−33.3%).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
Blue line: this share's price, −76.2% over these six months
The closing price of each day, from 93,050.00 on 2026-04-21 to 22,100.00 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −31.9%
Taken from the 1525 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −76.2%, the typical one −31.9%, 44.4 points behind. It is not an index and not a comparison within one industry.
This company: insiders buying per month, last 12 months
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| Seong-Wook Lee | CEO / chair | 1 | — | 32.3M KRW | 2026-07-10 | −33.3% |
Insiders' buying price vs the latest close
Insiders paid 32,304.70 KRW a share on average (3 purchase lines, 1 buyer, 2026-07-10 – 2026-07-10). The close on 2026-10-16 was 31.6% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
Other changes in holdings · 14
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-10-02 | Jong-Sun Rim | Director | Stock options(+) | 25,384 | DART ↗ |
| 2026-10-02 | Seungryul Han | Director | Stock options(+) | 45,800 | DART ↗ |
| 2026-10-02 | Sungwoo Hong | Vice president | Stock options(+) | 12,935 | DART ↗ |
| 2026-06-30 | Seungryul Han | Director | Acquisition of new shares without compensation(+) | 25,000 | DART ↗ |
| 2026-06-30 | Jong-Sun Rim | Director | Acquisition of new shares without compensation(+) | 25,308 | DART ↗ |
| 2026-06-30 | Sungwoo Hong | Vice president | Acquisition of new shares without compensation(+) | 75,000 | DART ↗ |
| 2026-06-30 | Seong-Wook Lee | CEO | Acquisition of new shares without compensation(+) | 2,245,000 | DART ↗ |
| 2026-06-12 | Sungwoo Hong | Vice president | Exercise of appraisal rights(+) | 37,000 | DART ↗ |
| 2026-06-12 | Sungwoo Hong | Vice president | Exercise of appraisal rights(+) | 20,000 | DART ↗ |
| 2025-12-24 | Sungwoo Hong | Vice president | Exercise of appraisal rights(+) | 18,000 | DART ↗ |
| 2025-12-18 | Jong-Sun Rim | Director | Exercise of appraisal rights(+) | 25,308 | DART ↗ |
| 2025-12-18 | Seungryul Han | Director | New listing(+) | 5,000 | DART ↗ |
| 2025-12-18 | Seungryul Han | Director | Exercise of appraisal rights(+) | 20,000 | DART ↗ |
| 2025-12-18 | Seong-Wook Lee | CEO | New listing(+) | 2,245,000 | DART ↗ |